Matricelf Ltd., a biotech firm focused on spinal cord injury therapies, has entered a collaboration with the CiRA Foundation, a leader in stem cell research. The partnership aims to integrate CiRA's induced pluripotent stem cells (iPSCs) with Matricelf's neural tissue engineering platform to develop automated, large-scale manufacturing of regenerative therapies. This collaboration could enhance production efficiency and reduce costs, supporting Matricelf's goal to expand access to advanced regenerative treatments. The project will assess the compatibility of the combined technologies by testing engineered neural tissues for genetic and functional markers, with successful results potentially paving the way for scalable manufacturing solutions.
The global automotive microcontrollers market is projected to grow from USD 15.49 billion in 2025 to USD 34.31 billion by 2035, at a CAGR of 8.28%. Growth is fueled by increasing adoption of advanced driver-assistance systems (ADAS), vehicle electrif...
Alpaca, a brokerage infrastructure startup, secured $435 million in funding to enter prime brokerage services, challenging traditional Wall Street firms. The company’s API supports 94% of US equities and powers tokenized stocks for Kraken. Alpaca’s t...
Raymond James Financial's rating was raised to "Buy" after positive investor event disclosures and a promising preview of its upcoming quarterly results. The company is expected to exceed earnings per share consensus for Q3 FY26, driven by strong per...
Whales have accumulated 70 million XRP over the past week, showing strong confidence despite XRP's price consolidating below resistance levels. The XRP Ledger surpassed 8 million activated accounts, indicating growing network adoption across payments...
Bunker Hill Mining Corp. has appointed Bradley Barnett as permanent CFO and Mark Hayes as General Counsel to support its transition to commercial production at the historic Bunker Hill Mine in Idaho. The company also achieved an improved 'A' grade in...
